[ClickPress, Fri Aug 23 2019] Long-term graft survival
in renal transplantation tends to be influenced by several risk factors, including acute rejection, donor origin and age, ethnic origin, human leukocyte antigen (HLA) mismatches, namely.
We performed a single-center retrospective study to obtain information about deceased kidney donors whose donations occurred from 2009 to 2011 in Puerto Rico and graft survival
in the transplant recipients who received those kidneys.
This analysis provided evidence that HBV chronic infection, which previously had a negative impact on patient and survival in kidney transplant patients, no longer influences patient or graft survival
due to the control of viral replication related to the extensive use of nucleos(t)ide analogues.
Indeed, DGF increases the risk of graft rejection and decreases graft survival
The determination of the effect of curcumin on autologous fat graft survival
in rats: Experimental study.
However, just as patient survival has increased over time, graft survival
in older adult transplant recipients has increased as well, despite an increase in the use of higher risk organs (McAdams-DeMarco et al., 2014).
The results obtained were statistically evaluated and the main parameters which were analysed were- Rate of granulation tissue formation, graft survival
, take-up and duration of hospital stay.
Standardized five-year graft survival
was similar for ODD and TDD grafts.
The 5-year kidney graft survival
was 95% and 100% in the negative and borderline biopsy groups respectively (p = NS).
Activated platelet-rich plasma improves fat graft survival
in nude mice: a pilot study.
It is generally accepted that severe macrovesicular steatosis [greater than or equal to] 60% leads to higher rates of primary nonfunction and EAD, and to reduced 1- and 3-year recipient and graft survival
[16, 22, 23], while mild steatotic organs seem to be safe to transplant [14,15, 24].
The present study was undertaken with the following aims: firstly, to know the prevalence of pretransplant antiMICA alloantibodies in patients undergoing live-related donor renal transplantation and its role in short-term graft survival
and secondly, to determine if there is a role of blood transfusions in formation of anti-MICA antibodies.
Transplants from ECD are known to perform worse than transplants from standard donors in terms of delayed graft function (DGF), primary nonfunction (PNF), short- and long-term renal function, and overall graft survival
[1-3], yet they may offer a survival advantage in comparison with not being transplanted and remaining on wait list, at least for specific patient categories [4-6].
Subsequently, several case series with a longer follow-up from different centers further verified the graft survival
, visual recovery, and related complications of DSAEK for the treatment of failed PKP.
Our study sheds necessary light on long-term graft survival
in populations with a high rate of consanguinity and many inherited genetic and metabolic etiologies for ESRD.